Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HSP90AB1 is a host factor that promotes porcine deltacoronavirus replication. | J Biol Chem | 2024 | 38092149 | PubTator, text mining | PubMed |
| A naturally occurring G11S mutation in the 3C-like protease from the SARS-CoV-2 virus dramatically weakens the dimer interface. | Protein Sci | 2024 | 38058248 | PubTator, text mining | PubMed |
| Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. | Antimicrob Agents Chemother | 2024 | 38047645 | PubTator, text mining | PubMed |
| Enterovirus D68 vRNA induces type III IFN production via MDA5. | Virus Res | 2024 | 38040125 | PubTator, text mining | PubMed |
| Forty years of HIV research inspires the development of SARS-CoV-2 therapy. | J Mol Cell Biol | 2024 | 37873695 | PubTator, text mining | PubMed |
| A community effort in SARS-CoV-2 drug discovery. | Mol Inform | 2024 | 37833243 | PubTator, text mining | PubMed |
| Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease. | bioRxiv | 2024 | 37502865 | PubTator, text mining | PubMed |
| In-vitro antiviral activity and in-silico targeted study of quinoline-3-carboxylate derivatives against SARS-Cov-2 isolate. | Mol Divers | 2024 | 37480422 | PubTator, text mining | PubMed |
Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability. | Mol Biotechnol | 2024 | 36463562 | PubTator, text mining | PubMed |
| A Longitudinal Study of NADC34-Like Strains in an Intensive Farm Unravels Divergent Evolution. | Transbound Emerg Dis | 2023 | 40303739 | PubTator, text mining | PubMed |
| Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients. | Microorganisms | 2023 | 38276171 | PubTator, text mining | PubMed |
| Nutritional and Wellness Strategies for Neurological and Psychiatric Recovery From Post-COVID Syndrome and Post-acute Sequelae of COVID-19. | Cureus | 2023 | 38269219 | PubTator, text mining | PubMed |
| Identification of Putative Novel Rotavirus H VP7, VP4, VP6 and NSP4 Genotypes in Pigs. | Viruses | 2023 | 38257768 | PubTator, text mining | PubMed |
| Structural Basis for the Inhibition of SARS-CoV-2 Mpro D48N Mutant by Shikonin and PF-07321332. | Viruses | 2023 | 38257765 | PubTator, text mining | PubMed |
| Isolation and Pathogenicity Analysis of a G5P[23] Porcine Rotavirus Strain. | Viruses | 2023 | 38257722 | PubTator, text mining | PubMed |
| AEN Suppresses the Replication of Porcine Epidemic Diarrhea Virus by Inducing the Expression of Type I IFN and ISGs in MARC-145 Cells. | Pathogens | 2023 | 38251332 | PubTator, text mining | PubMed |
| A multiplex real-time fluorescence-based quantitative PCR assay for calf diarrhea viruses. | Front Microbiol | 2023 | 38249490 | PubTator, text mining | PubMed |
| Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases. | Front Microbiol | 2023 | 38249451 | PubTator, text mining | PubMed |
| Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2. | iScience | 2023 | 38213785 | PubTator, text mining | PubMed |
| A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety. | Infect Med (Beijing) | 2023 | 38205179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=10